112
|
348
|
4fv7A |
Crystal structure of the erk2 complexed with e94 |
106
|
342
|
4g3eA |
Crystal structure of murine nf-kappab inducing kinase (nik) bound to a 6-alkynylindoline (cmp1) |
83
|
278
|
4ft7A |
Crystal structure of the chk1 |
93
|
354
|
4g1wA |
Crystal structure of jnk1 in complex with jip1 peptide and 7-fluoro-3-[4-(2-hydroxy-ethanesulfonyl)-benzyl]-4-oxo-1-phenyl-1,4-dihydro-quinoline-2-carboxylic acid methyl ester |
80
|
279
|
4ftcA |
Crystal structure of the chk1 |
108
|
349
|
4fv6A |
Crystal structure of the erk2 complexed with e57 |
81
|
278
|
4fswA |
Crystal structure of the chk1 |
80
|
268
|
4fstA |
Crystal structure of the chk1 |
82
|
269
|
4ftrA |
Crystal structure of the chk1 |
83
|
279
|
4ft9A |
Crystal structure of the chk1 |
89
|
277
|
4fynA |
Crystal structure of spleen tyrosine kinase complexed with 3-(8-{4-[ethyl-(2-hydroxy-ethyl)-amino]-phenylamino}-imidazo[1,2-a]pyrazin-5-yl)-phenol |
107
|
360
|
4fr4A |
Crystal structure of human serine/threonine-protein kinase 32a (yank1) |
103
|
348
|
4fv0A |
Crystal structure of the erk2 complexed with ek3 |
83
|
278
|
4ftuA |
Crystal structure of the chk1 |
85
|
285
|
4g34A |
Crystal structure of gsk6924 bound to perk (r587-r1092, delete a660-t867) at 2.70 a resolution |
96
|
302
|
4g16A |
Crystal structure of ck1g3 with 2-[(4-{[3-(trifluoromethyl)pyridin2-yl]oxy}phenyl)amino]-1h-benzimidazole-6-carbonitrile |
82
|
278
|
4ftaA |
Crystal structure of the chk1 |
87
|
277
|
4fz7A |
Crystal structure of spleen tyrosine kinase complexed with 6-((1r,2s)-2-amino-cyclohexylamino)-4-(6-ethyl-pyridin-2-ylamino)-pyridazine-3-carboxylic acid amide |
79
|
277
|
4ftiA |
Crystal structure of the chk1 |
92
|
310
|
4fnzA |
Crystal structure of human anaplastic lymphoma kinase in complex with piperidine-carboxamide inhibitor 2 |
78
|
278
|
4ftmA |
Crystal structure of the chk1 |
81
|
278
|
4fsyA |
Crystal structure of the chk1 |
80
|
298
|
4fx3A |
Crystal structure of the cdk2/cyclin a complex with oxindole inhibitor |
78
|
268
|
4fsuA |
Crystal structure of the chk1 |
105
|
347
|
4fv3A |
Crystal structure of the erk2 complexed with ek6 |
81
|
278
|
4ft5A |
Crystal structure of the chk1 |
81
|
286
|
4g31A |
Crystal structure of gsk6414 bound to perk (r587-r1092, delete a660-t867) at 2.28 a resolution |
81
|
277
|
4ftjA |
Crystal structure of the chk1 |
76
|
278
|
4ftlA |
Crystal structure of the chk1 |
88
|
277
|
4fyoA |
Crystal structure of spleen tyrosine kinase complexed with n-{(s)-1-[7-(3,4-dimethoxy-phenylamino)-thiazolo[5,4-d]pyrimidin-5-yl]-pyrrolidin-3-yl}-terephthalamic acid |
108
|
347
|
4fv2A |
Crystal structure of the erk2 complexed with ek5 |
83
|
278
|
4fsnA |
Crystal structure of the chk1 |
105
|
348
|
4fuyA |
Crystal structure of the erk2 complexed with ek2 |
78
|
278
|
4ftkA |
Crystal structure of the chk1 |
80
|
281
|
4fzdB |
Crystal structure of mst4-mo25 complex with wsf motif |
82
|
278
|
4ft0A |
Crystal structure of the chk1 |
111
|
350
|
4fv8A |
Crystal structure of the erk2 complexed with e63 |
103
|
350
|
4fv9A |
Crystal structure of the erk2 complexed with e71 |
80
|
269
|
4ftnA |
Crystal structure of the chk1 |
90
|
295
|
4g2fA |
Human epha3 kinase domain in complex with compound 7 |
83
|
278
|
4fttA |
Crystal structure of the chk1 |
85
|
281
|
4fzaB |
Crystal structure of mst4-mo25 complex |
80
|
278
|
4fsmA |
Crystal structure of the chk1 |
85
|
274
|
4fvqA |
Crystal structure of the jak2 pseudokinase domain (mg-atp-bound form) |
105
|
347
|
4fuxA |
Crystal structure of the erk2 complexed with e75 |
79
|
268
|
4ftqA |
Crystal structure of the chk1 |
83
|
274
|
4fvrA |
Crystal structure of the jak2 pseudokinase domain mutant v617f (mg-atp-bound form) |
82
|
278
|
4fsqA |
Crystal structure of the chk1 |
86
|
274
|
4fvpA |
Crystal structure of the jak2 pseudokinase domain (apo form) |
98
|
349
|
4fv5A |
Crystal structure of the erk2 complexed with ek9 |